Home >> Tag Archives: Oxford Gene Technology—

Tag Archives: Oxford Gene Technology—

OGT expands sales support in Europe

October 2018—Oxford Gene Technology announced it is selling its Cytocell fluorescence in situ hybridization products through several affiliates of Sysmex Corp. in Europe. “The move is a testament to the ongoing successful integration of the two companies and commitment to combine efforts to support and serve end users,” according to a press release from OGT.

Read More »

SureSeq NGS analysis software

September 2018—Oxford Gene Technology launched its SureSeq Interpret software, designed to be used with SureSeq NGS panels, to analyze and visualize a range of mutation types and structural variants. The software rapidly processes sequencing data and delivers accurate mutation calling with 100 percent sensitivity and 99.9 percent specificity at >1 percent variant allele frequency.

Read More »

SureSeq NGS analysis software

September 2018—Oxford Gene Technology launched its SureSeq Interpret software, designed to be used with SureSeq NGS panels, to analyze and visualize a range of mutation types and structural variants. The software rapidly processes sequencing data and delivers accurate mutation calling with 100 percent sensitivity and 99.9 percent specificity at >1 percent variant allele frequency.

Read More »

OGT expands custom NGS cancer panel content

June 18, 2018—Oxford Gene Technology has expanded its SureSeq myPanel NGS Custom Cancer Panel content, which now covers 120 fully optimized cancer-related genes. OGT’s solid tumor and hematology custom panel content enables users to sequence genes and regions relevant to their cancer research. The preoptimized panel content aims to facilitate the development of robust NGS assays, whether these are working ...

Read More »

Sysmex acquires OGT

June 16, 2017—Sysmex has reached an agreement with Oxford Gene Technology to acquire all shares in OGT, which will become a wholly owned subsidiary of Sysmex. With this acquisition, Sysmex aims to obtain OGT’s business and expertise in the cytogenetics domain and its reagent development capabilities used in next-generation sequencers, thereby reinforcing its base in the life science business. Sysmex ...

Read More »

NGS cancer panels, 6/17

June 2017—Oxford Gene Technology has expanded its SureSeq myPanel NGS Custom Cancer Panel content. The expanded content covers more than 70 genes optimized for hematology and solid tumors including breast, colorectal, lung, ovarian and prostate cancer, glioma, melanoma, sarcoma, leukemias, myeloproliferative neoplasms, and myelodysplastic syndrome.

Read More »

FISH probes, 9/16

September 2016—Oxford Gene Technology has expanded its catalog of fluorescence in situ hybridization products with nine Cytocell Aquarius probes: ETV6 Proximal Probe Green, ETV6 Distal Probe Red, MPO Probe Red, TP53 Probe Green, NUP214 Probe Red, DEK Probe Green, TAS2R1 (5p15.31) Probe Green, Chromosome 9 Satellite III Probe Aqua, and Chromosome 15 Alpha Satellite Probe Red.

Read More »
X